| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 79,12% | 100,75% | 99,20% | 382,31% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I (CLOSE) EUR CAP | RVI EMERGENTES | 79,02% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO R (CLOSE) GBP CAP | RVI EMERGENTES | 78,98% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO I (CLOSE) USD CAP | RVI EMERGENTES | 78,89% | · | · | · |
| PICTET - BIOTECH HI EUR | RVI BIOTECNOLOGÍA | 78,86% | 88,72% | 44,99% | 129,56% |
| ROBECO SMART ENERGY X USD | RVI ENERGÍA | 78,85% | 98,81% | 111,98% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO R (CLOSE) USD CAP | RVI EMERGENTES | 78,84% | · | · | · |
| SCHRODER ISF GLOBAL GOLD IZ ACC USD | RVI MATERIAS PRIMAS | 78,84% | 249,22% | 237,25% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO R (CLOSE) EUR CAP | RVI EMERGENTES | 78,82% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO P (CLOSE) GBP CAP | RVI EMERGENTES | 78,76% | · | · | · |
